US Stock MarketDetailed Quotes
BNR Burning Rock Biotech
- 5.630
- +0.030+0.54%
Trading Nov 25 11:37 ET
57.76MMarket Cap-737P/E (TTM)
5.766High5.341Low7.63KVolume5.550Open5.600Pre Close42.15KTurnover0.17%Turnover RatioLossP/E (Static)10.26MShares9.98752wk High0.62P/B25.83MFloat Cap2.62052wk Low--Dividend TTM4.59MShs Float397.500Historical High--Div YieldTTM7.59%Amplitude2.620Historical Low5.524Avg Price1Lot Size
Burning Rock Biotech Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 44.01%-255.78M | 4.41%-456.81M | ||||||||
| Net income from continuing operations | ---- | ---- | 32.69%-653.69M | ---- | ---- | ---- | ---- | -21.91%-971.23M | ---- | ---- |
| Operating gains losses | ---- | ---- | -20.04%1.37M | ---- | ---- | ---- | ---- | 159.00%1.71M | ---- | ---- |
| Depreciation and amortization | ---- | ---- | 7.50%133.4M | ---- | ---- | ---- | ---- | 159.80%124.1M | ---- | ---- |
| Other non cash items | ---- | ---- | -4.84%35.18M | ---- | ---- | ---- | ---- | 3.82%36.97M | ---- | ---- |
| Change In working capital | ---- | ---- | -367.40%-52.16M | ---- | ---- | ---- | ---- | 82.12%-11.16M | ---- | ---- |
| -Change in receivables | ---- | ---- | 61.11%-16.4M | ---- | ---- | ---- | ---- | 14.92%-42.16M | ---- | ---- |
| -Change in inventory | ---- | ---- | 364.51%57.28M | ---- | ---- | ---- | ---- | 67.68%-21.65M | ---- | ---- |
| -Change in prepaid assets | ---- | ---- | -63.58%12.35M | ---- | ---- | ---- | ---- | 197.30%33.92M | ---- | ---- |
| -Change in payables and accrued expense | ---- | ---- | -200.15%-50.37M | ---- | ---- | ---- | ---- | 28.49%50.29M | ---- | ---- |
| -Change in other current liabilities | ---- | ---- | 0.18%-37.74M | ---- | ---- | ---- | ---- | -107.97%-37.81M | ---- | ---- |
| -Change in other working capital | ---- | ---- | -376.13%-17.28M | ---- | ---- | ---- | ---- | -90.81%6.26M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 48.44%-40.84M | 64.46%-40.21M | 44.01%-255.78M | 76.34%-16.02M | 65.00%-47.42M | 27.52%-79.2M | 21.62%-113.14M | 4.41%-456.81M | 39.74%-67.71M | -1.55%-135.47M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -24.61%-9.3M | -109.13%-7.46M | ||||||||
| Net PPE purchase and sale | ---- | ---- | 88.18%-8.02M | ---- | ---- | ---- | ---- | 67.73%-67.88M | ---- | ---- |
| Net intangibles purchase and sale | ---- | ---- | -591.89%-1.28M | ---- | ---- | ---- | ---- | 92.68%-185K | ---- | ---- |
| Net investment purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -77.73%65.6M | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---5M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 92.25%-227K | 41.22%-2.39M | -24.61%-9.3M | 93.48%-328K | 90.15%-1.99M | -109.53%-2.93M | 68.80%-4.06M | -109.13%-7.46M | 92.48%-5.03M | 72.05%-20.15M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 43.38%-48.83M | -63.03%-86.24M | ||||||||
| Net issuance payments of debt | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 94.71%-2.37M | ---- | ---- |
| Net common stock issuance | ---- | ---- | 90.29%-6.98M | ---- | ---- | ---- | ---- | -1,582.30%-71.83M | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | -247.78%-41.86M | ---- | ---- | ---- | ---- | -214.81%-12.04M | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | 43.38%-48.83M | 81.05%-1.91M | -1,618.01%-45.89M | 98.56%-1M | 99.19%-32K | -63.03%-86.24M | -48.58%-10.08M | 91.90%-2.67M |
| Net cash flow | ||||||||||
| Beginning cash position | -28.70%572.67M | -33.51%615.22M | -35.71%925.27M | -37.20%636.75M | -36.41%733.28M | -37.00%803.14M | -35.71%925.27M | -25.25%1.44B | -38.53%1.01B | -38.77%1.15B |
| Current changes in cash | 50.61%-41.06M | 63.67%-42.6M | 42.98%-313.92M | 77.96%-18.26M | 39.80%-95.29M | 43.87%-83.14M | 27.32%-117.23M | -22.58%-550.51M | 55.50%-82.82M | 33.63%-158.29M |
| Effect of exchange rate changes | -89.18%1.44M | 101.08%53K | -89.46%3.86M | 44.68%-3.28M | -106.44%-1.24M | -49.50%13.27M | -66.91%-4.89M | 199.08%36.67M | 75.82%-5.92M | 291.18%19.24M |
| End cash Position | -27.31%533.05M | -28.70%572.67M | -33.51%615.22M | -33.51%615.22M | -37.20%636.75M | -36.41%733.28M | -37.00%803.14M | -35.71%925.27M | -35.71%925.27M | -38.53%1.01B |
| Free cash flow | 48.44%-40.84M | 64.46%-40.21M | 49.71%-265.17M | 81.62%-25.4M | 65.00%-47.42M | 27.52%-79.2M | 21.62%-113.14M | 23.73%-527.28M | 57.59%-138.18M | -1.55%-135.47M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data